Indications and uses
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache premenstrual and menstrual cramps the common cold headache toothache temporarily reduces fever
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache premenstrual and menstrual cramps the common cold headache toothache temporarily reduces fever
do not take more than directed (see overdose warning ) adults take 2 caplets every 8 hours with water swallow whole; do not crush, chew, split or dissolve do not take more than 6 caplets in 24 hours do not use for more than 10 days unless directed by a doctor under 18 years of age ask a doctor
store between 20-25°C (68-77°F) do not use if carton is opened. Do not use if foil inner seal imprinted with "TYLENOL" is broken or missing
Drug Facts
Acetaminophen 650 mg
Pain reliever/fever reducer
This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
Ask a doctor before use if you have liver disease
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
| adults |
|
| under 18 years of age |
|
carnauba wax, hydroxyethyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, modified starch, povidone, powdered cellulose, pregelatinized starch, sodium starch glycolate, titanium dioxide, triacetin
call 1-877-895-3665 (toll-free) or 215-273-8755 (collect)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1148399 | acetaminophen 650 MG 8HR Extended Release Oral Tablet | PSN | 16 |
| 1243440 | Tylenol 650 MG 8HR Extended Release Oral Tablet | PSN | 16 |
| 1243440 | 8 HR acetaminophen 650 MG Extended Release Oral Tablet [Tylenol] | SBD | 16 |
| 1148399 | 8 HR acetaminophen 650 MG Extended Release Oral Tablet | SCD | 16 |
| 1148399 | 8 HR APAP 650 MG Extended Release Oral Tablet | SY | 16 |
| 1243440 | 8 HR APAP 650 MG Extended Release Oral Tablet [Tylenol] | SY | 16 |
| 1148399 | acetaminophen 650 MG 8 HR Extended Release Oral Tablet | SY | 16 |
| 1243440 | Tylenol 650 MG 8 HR Extended Release Oral Tablet | SY | 16 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50580-783-10 | Tylenol 8 HR Arthritis Pain | 100 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 100 | 16 | |
| 50580-783-10 | Tylenol 8 HR Arthritis Pain | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 16 | |
| 50580-783-24 | Tylenol 8 HR Arthritis Pain | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 16 | |
| 50580-783-24 | Tylenol 8 HR Arthritis Pain | 24 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 24 | 16 | |
| 50580-783-25 | Tylenol 8 HR Arthritis Pain | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 16 | |
| 50580-783-25 | Tylenol 8 HR Arthritis Pain | 225 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 225 | 16 | |
| 50580-783-29 | Tylenol 8 HR Arthritis Pain | 290 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 290 | 16 | |
| 50580-783-29 | Tylenol 8 HR Arthritis Pain | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 16 | |
| 50580-783-30 | Tylenol 8 HR Arthritis Pain | 290 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 290 | 16 | |
| 50580-783-31 | Tylenol 8 HR Arthritis Pain | 50 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 50 | 16 | |
| 50580-783-31 | Tylenol 8 HR Arthritis Pain | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 16 | |
| 50580-783-32 | Tylenol 8 HR Arthritis Pain | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 16 | |
| 50580-783-32 | Tylenol 8 HR Arthritis Pain | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 16 | |
| 50580-783-51 | Tylenol 8 HR Arthritis Pain | 2 in 1 POUCH | TABLET, EXTENDED RELEASE | 2 | 16 | |
| 50580-783-51 | Tylenol 8 HR Arthritis Pain | 50 in 1 CARTON | TABLET, EXTENDED RELEASE | 50 | 16 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-783-10 | EA - Each | 50580-783 | c041eb5a-b9a4-4192-86dd-d198b9693ec2 | 1 | 2017-04-05 |
| 50580-783-24 | EA - Each | 50580-783 | 1652964d-fe0b-44f0-903d-4c6c38350d11 | 1 | 2022-07-06 |
| 50580-783-25 | EA - Each | 50580-783 | 9a54be68-ab11-44c4-b0e8-9c29e0770c3f | 1 | 2017-04-05 |
| 50580-783-30 | EA - Each | 50580-783 | c4c4a604-7575-48e5-87fc-5606ce30c89d | 1 | 2024-05-16 |
| 50580-783-31 | EA - Each | 50580-783 | e68cd84a-6983-4afb-b320-9fb90c72d39a | 1 | 2022-08-04 |
| 50580-783-32 | EA - Each | 50580-783 | 1a2bb08a-9832-42da-83c7-d96bea0f79b9 | 1 | 2020-09-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Acetaminophen | ACTIVE INGREDIENT | 362O9ITL9D | 1 | |
| Acetaminophen | ACTIVE MOIETY | 362O9ITL9D | 1 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| hydroxyethyl cellulose (140 mpa.s at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| powdered cellulose | INACTIVE INGREDIENT | SMD1X3XO9M | 1 | |
| sodium starch glycolate type a potato | INACTIVE INGREDIENT | 5856J3G2A2 | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| triacetin | INACTIVE INGREDIENT | XHX3C3X673 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50580-783 | 50580-783-10, 50580-783-24, 50580-783-25, 50580-783-29, 50580-783-30, 50580-783-32, 50580-783-31, 50580-783-51 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| hydroxyethyl cellulose (140 mpa.s at 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| triacetin | TRIACETIN | XHX3C3X673 | TABLET, EXTENDED RELEASE / ORAL | 26 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, EXTENDED RELEASE / ORAL | 2150 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019872-001 | TYLENOL | ACETAMINOPHEN | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | |
| N019872-002 | TYLENOL | ACETAMINOPHEN | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019872-001 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 1994-06-08 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019872-002 | TYLENOL | 650MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2001-01-11 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tylenol 8 HR Arthritis Pain | ACETAMINOPHEN | Kenvue Brands LLC | 3af22fc8-e4e0-4863-8696-6bc1257047cb | 2024-11-13 | Warnings | 50580-783-30 50580-783-32 50580-783-25 50580-783-24 50580-783-29 50580-783-10 50580-783-51 50580-783-31 50580-783 50580078351 50580078310 50580078324 50580078325 50580078329 50580078330 50580078332 50580078331 26c62e88-08c4-1113-e063-6394a90ac1f8 3af22fc8-e4e0-4863-8696-6bc1257047cb |
Adverse event summaries are temporarily unavailable. Other product information remains available.